Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
α-Defensins and outcome in patients with chronic heart failure.
Christensen HM, Frystyk J, Faber J, Schou M, Flyvbjerg A, Hildebrandt P, Raymond I, Klausen TW, Kistorp C. Christensen HM, et al. Among authors: faber j. Eur J Heart Fail. 2012 Apr;14(4):387-94. doi: 10.1093/eurjhf/hfs021. Epub 2012 Feb 22. Eur J Heart Fail. 2012. PMID: 22357441 Free article.
Fatigue, health-related quality-of-life and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer: A randomised clinical trial (HEAT).
Ternov KK, Sønksen J, Fode M, Lindberg H, Kistorp C, Bisbjerg R, Faber J, Klausen TW, Palapattu G, Østergren PB. Ternov KK, et al. Among authors: faber j. Eur J Cancer. 2022 Aug;171:75-84. doi: 10.1016/j.ejca.2022.04.034. Epub 2022 Jun 13. Eur J Cancer. 2022. PMID: 35709600 Clinical Trial.
The effect of liraglutide on renal function: A randomized clinical trial.
von Scholten BJ, Persson F, Rosenlund S, Hovind P, Faber J, Hansen TW, Rossing P. von Scholten BJ, et al. Among authors: faber j. Diabetes Obes Metab. 2017 Feb;19(2):239-247. doi: 10.1111/dom.12808. Epub 2016 Nov 21. Diabetes Obes Metab. 2017. PMID: 27753201 Clinical Trial.
Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial).
Johansen ML, Schou M, Rossignol P, Holm MR, Rasmussen J, Brandt N, Frandsen M, Chabanova E, Dela F, Faber J, Kistorp C. Johansen ML, et al. Among authors: faber j. Diabetes Obes Metab. 2019 Oct;21(10):2305-2314. doi: 10.1111/dom.13809. Epub 2019 Jul 5. Diabetes Obes Metab. 2019. PMID: 31183945 Clinical Trial.
1,338 results